Loading...
Effects of tolvaptan on renal function in chronic kidney disease patients with volume overload
BACKGROUND: Fluid overload in chronic kidney disease (CKD) is generally controlled by diuretics, with potentially harmful effects on renal function. The efficacy of tolvaptan, a vasopressin V2-receptor antagonist and aquaretic, has not been evaluated for fluid control in CKD with reduced renal funct...
Saved in:
| Published in: | Int J Nephrol Renovasc Dis |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6103308/ https://ncbi.nlm.nih.gov/pubmed/30147354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S167694 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|